SQN announces significant enhancement to EDC and Clinical Trial Management System

NewsGuard 100/100 Score

Syne qua non (SQN), today announced a significant enhancement to their EDC and Clinical Trial Management System, Syne-clin®. A senior clinical research professional recently described Syne-clin® as delivering the ease of use and functionality that many envisaged EDC should have delivered when it was first introduced decades ago.

SQN have incorporated the wishes and feedback from many involved in clinical research, involving hundreds of clinical trials hosted in many countries. Rapid study start up coupled with innovative PDF based eCRFs with a paper look and feel, simplify the data collection process. Advanced real-time data validation and flexible drill down reporting through innovative project dashboards are additional reasons why the system is being received so positively across the industry.

One of the significant benefits of this new release is the ability to utilise new and emerging mobile technology. Tablet PCs and Smartphone devices enrich the PDF based eCRF collection experience. Multimedia, touch based interactive data entry screens, local language support, image management and helpful completion guidelines are provided as standard. Even in situations where the Internet is not available, secure 'offline' eCRF forms can collect data while retaining real-time data validation functionality, something that most EDC solutions cannot deliver. In addition, the solution offers hybrid paper and EDC data capture options. Syne-clin® meets prevailing regulatory guidelines including FDA 21 CFR Part 11 and has been audited recently by a leading regulatory agency as well as specialist QA/IT auditors from global pharma and biotech companies.

Source:

Syne qua non (SQN)    

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Korean fermented food Doenjang shows promise in alleviating menopausal symptoms